The share of US scientific publications in the world's top 10% cited in immunology is projected to slightly decline from 12.99% in 2024 to 12.65% in 2028. In 2023, this figure stood at a slightly higher rate, indicating a gradual decrease. Year-on-year, this represents a consistent decline of about 0.63% annually over the forecast period. The compound annual growth rate (CAGR) suggests an even smaller annual reduction in influence over the five-year span.
Future trends to watch for include emerging scientific collaborations, shifts in global research funding, breakthroughs in immunological sciences, and the impact of evolving academic publishing standards, all of which could affect the citation dynamics for US-based publications relative to global peers.
